Syra Health Corp. Class A Common Stock (SYRA)
$
0.09
-0.01 (-11.11%)
Key metrics
Financial statements
Free cash flow per share
-0.1708
Market cap
1 Million
Price to sales ratio
0.1255
Debt to equity
0.0528
Current ratio
2.8811
Income quality
0.7086
Average inventory
0
ROE
-1.0353
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Syra Health Corp., a prominent healthcare services company, operates within the United States, focusing on various essential sectors such as health education, population health management, behavioral and mental health, healthcare workforce, and digital health services. The weighted average number of shares outstanding is 7,264,768.00 highlighting the company's shareholder base and its engagement within the financial market. Additionally, the weighted average number of diluted shares outstanding stands at 7,264,768.00 reflecting the potential dilution effects that may impact shareholders. The company has incurred an interest expense of $15,600.00 which underscores its debt servicing obligations and the financial responsibilities it maintains. Syra Health Corp.'s stock is identified with the symbol 'SYRA' in the market, allowing investors to track its performance. The net income ratio is -0.47 reflecting the company's profitability margin while demonstrating its operational effectiveness and ability to generate profits in a competitive landscape. Apart from these financial metrics, Syra Health Corp. is also known for its significant offerings including health education services such as medical communications and patient education, along with population health management services like analytics as a service and health equity analytics solutions. The development of Syrenity, an on-demand telehealth platform for mental health services, exemplifies the company's commitment to innovation, while it also provides healthcare staffing solutions and digital health advancements focused on areas like artificial intelligence and patient engagement. In the current market, the stock is affordable at $0.09 making it suitable for budget-conscious investors eager to engage with a promising company. However, it is important to note that the stock has a low average trading volume of 278,278.00 indicating lower market activity and potentially higher volatility. With a market capitalization of $1,014,831.00 the company is classified as a small-cap player, representing a unique opportunity for growth within this segment. Syra Health Corp. stands out as a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape and driving innovation and growth. Furthermore, it belongs to the Healthcare sector, where continued advancements and developments are vital for fostering a healthier and more efficient healthcare system.
Is Syra Health Corp. Class A Common Stock (SYRA) a good investment?
Investing in Syra Health Corp. Class A Common Stock (SYRA) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bullish outlook. Always conduct your own research before investing.
What is Syra Health Corp. Class A Common Stock (SYRA)'s stock forecast?
Analysts predict Syra Health Corp. Class A Common Stock stock to fluctuate between $0.03 (low) and $1.71 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Syra Health Corp. Class A Common Stock's market capitalization?
As of 2025-07-08, Syra Health Corp. Class A Common Stock's market cap is $1,014,831, based on 11,939,192 outstanding shares.
How does Syra Health Corp. Class A Common Stock compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Syra Health Corp. Class A Common Stock has a Lower Market-Cap, indicating a difference in performance.
How can I buy Syra Health Corp. Class A Common Stock (SYRA) stock?
To buy Syra Health Corp. Class A Common Stock (SYRA) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SYRA. Place an order (Market, Limit, etc.).
What is the best time to invest in Syra Health Corp. Class A Common Stock?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Syra Health Corp. Class A Common Stock perform in the last earnings report?
Revenue: $7,982,082 | EPS: -$0.52 | Growth: -13.33%.
Where can I find Syra Health Corp. Class A Common Stock's investor relations reports?
Visit https://www.syrahealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Syra Health Corp. Class A Common Stock?
You can explore historical data from here
What is the all-time high and low for Syra Health Corp. Class A Common Stock stock?
All-time high: $8.37 (2024-02-08) | All-time low: $0.03 (2025-04-21).
What are the key trends affecting Syra Health Corp. Class A Common Stock stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
CARMEL, Ind. , May 27, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that the Indiana Department of Administration in collaboration with the Family and Social Services Administration/Division of Mental Health and Addiction has recommended Syra Health for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site.
seekingalpha.com
Syra Health Corp. (OTC:SYRA) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Corbin Woodhull - Hayden Investor Relations Dr. Deepika Vuppalanchi - Chief Executive Officer Priya Prasad - Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen. And welcome to the Syra Health First Quarter 2025 Earnings Conference Call.
prnewswire.com
CARMEL, Ind. , March 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health contract extension with a national healthcare organization.
seekingalpha.com
Syra Health Corp. (NASDAQ:SYRA ) Q4 2024 Earnings Call March 11, 2025 9:00 AM ET Company Participants Brett Maas - Investor Relations Deepika Vuppalanchi - Chair and Chief Executive Officer Priya Prasad - Chief Financial Officer Brett Maas Good morning, everyone, and thank you for joining us for Syra Health's Fourth Quarter and Full Year 2024 Financial Results Conference Call. My name is Brett Maas of Hayden IR, and I direct Investor Relations for Syra Health.
prnewswire.com
2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind. , March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.
prnewswire.com
CARMEL, Ind. , Feb. 25, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a $450,000 contract extension with the Shelby County Health Department in Tennessee.
prnewswire.com
CARMEL, Ind. , Feb. 18, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today positive preliminary results from the clinical research study being conducted by Indiana University (IU) of its flagship mental health product, Syrenity.
prnewswire.com
CARMEL, Ind. , Feb. 13, 2025 /PRNewswire/ -- Syra Health Corp. (Nasdaq: SYRA), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a six-month, $135,000 contract with a Midwest-based university to develop prevention-focused virtual training modules in behavioral health.
See all news
